Who Paid My Doc
Qian Yang
Oral & Maxillofacial Surgery Boston, MA Doctor of Dentistry
NPI 1003256512 CMS profile 1103669
55 Fruit St., Massachusetts General Hospital, Boston, MA 02114
General payments
$480
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Qian Yang of Boston, MA is reported in the CMS Open Payments database as having received $480 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 38th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $155 | 8 | |
| 2022 | General | $325 | 4 |
Beside peers
- Qian Yang
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Qian Yang were reported at $0. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Qian Yang | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $178 | $56–$584 | $163 |
| 2020 | $0 | $106 | $38–$316 | $114 |
| 2021 | $0 | $165 | $57–$511 | $132 |
| 2022 | $325 | $173 | $63–$494 | $149 |
| 2023 | $155 | $184 | $62–$521 | $160 |
| 2024 | $0 | $197 | $65–$603 | $164 |
| 2025 | $0 | $184 | $61–$541 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 10 drugsPart D claims
541
Drug cost
$1,809
Branded share of claims
15%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 211 | $677 | |
| Penicillin V Potassium | Generic | 87 | $251 | |
| Lidocaine Hcl Viscous Lidocaine Hcl | Brand | 33 | $248 | |
| Ibuprofen | Generic | 84 | $210 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 32 | $152 | |
| Dexamethasone | Generic | 25 | $85 | |
| Amoxicillin | Generic | 25 | $61 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 16 | $59 | |
| Azithromycin | Generic | 15 | $41 | |
| Oxycodone Hcl | Generic | 13 | $26 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Massachusetts
Briana Burris
Oral & Maxillofacial Surgery · Boston, MA
Cory Resnick
Oral & Maxillofacial Surgery · Boston, MA
Miguel Vidal
Oral & Maxillofacial Surgery · Boston, MA
Timothy Osborn
Oral & Maxillofacial Surgery · Medford, MA
Jeffrey Hajibandeh
Oral & Maxillofacial Surgery · Boston, MA
Zachary Peacock
Oral & Maxillofacial Surgery · Boston, MA
Related records
Oral & Maxillofacial Surgery in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.